TrialInternational journal of clinical practice2011

One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial.

R Pratley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.